Baidu
map

Diabetes Care:青年2型糖尿病患者肾脏不良转归危险升高

2012-03-31 MedSci MedSci原创

3月19日,《糖尿病护理》杂志(Diabetes care)发表的加拿大学者的一项研究表明,2型糖尿病青年患者的不良肾脏转归和死亡风险均升高;蛋白尿和肾素-血管紧张素-醛固酮系统抑制剂应用与成年早期转归不佳相关。(Diabetes care.2012-03-19) 此项研究共纳入342例2型糖尿病青年患者、1011例2型糖尿病青年患者以及1710例对照者,并利用ICD编码对远期转归进行评估。

3月19日,《糖尿病护理》杂志(Diabetes care)发表的加拿大学者的一项研究表明,2型糖尿病青年患者的不良肾脏转归和死亡风险均升高;蛋白尿和肾素-血管紧张素-醛固酮系统抑制剂应用与成年早期转归不佳相关。(Diabetes care.2012-03-19)

此项研究共纳入342例2型糖尿病青年患者、1011例2型糖尿病青年患者以及1710例对照者,并利用ICD编码对远期转归进行评估。

结果显示,与1型糖尿病青年患者相比,2型糖尿病青年患者的肾衰风险升高4倍。与肾衰相关的危险因素为肾素-血管紧张素-醛固酮系统抑制剂应用和青春期蛋白尿。与年龄、性别和地域相匹配的对照者相比,2型糖尿病青年患者的肾衰风险升高23倍,透析风险升高39倍。2型和1型糖尿病组的10年时Kaplan-Meier生存率分别为91.4%和99.5%(P<0.0001)。两组10年时肾脏生存率均为100%。15和20年时2型糖尿病组分别降低至92.0%和55.0%,但1型糖尿病组保持稳定(P<0.0001)。

High Burden of Kidney Disease in Youth-Onset Type 2 Diabetes

Allison B. Dart, Elizabeth A. Sellers, Patricia J. Martens, Claudio Rigatto, Marni D. Brownell, and Heather J. Dean

Abstract: OBJECTIVETo evaluate renal outcomes and survival in youth with type 2 diabetes versus type 1 diabetes versus nondiabetic control subjects.RESEARCH DESIGN AND METHODSIn total, 342 prevalent youth (aged 1-18 years) with type 2 diabetes, 1,011 youth with type 1 diabetes, and 1,710 control subjects iden... OBJECTIVETo evaluate renal outcomes and survival in youth with type 2 diabetes versus type 1 diabetes versus nondiabetic control subjects.RESEARCH DESIGN AND METHODSIn total, 342 prevalent youth (aged 1-18 years) with type 2 diabetes, 1,011 youth with type 1 diabetes, and 1,710 control subjects identified from 1986 to 2007 were anonymously linked to health care records housed at the Manitoba Centre for Health Policy to assess long-term outcomes using ICD codes.RESULTSYouth with type 2 diabetes were found to have a fourfold increased risk of renal failure versus youth with type 1 diabetes. Risk factors associated with renal failure were renin angiotensin aldosterone system inhibitor use and albuminuria in adolescence. Compared with control subjects (age, sex, and postal code matched), youth with type 2 diabetes had a 23-fold increased risk of renal failure and a 39-fold increased risk of dialysis. Kaplan-Meier survival at 10 years was 91.4% in the type 2 diabetic group versus 99.5% in the type 1 diabetic group (P < 0.0001). Renal survival was 100% at 10 years in both groups. It decreased to 92.0% at 15 years and 55.0% at 20 years in the type 2 diabetic group but remained stable in the type 1 diabetic group (P < 0.0001).CONCLUSIONSYouth with type 2 diabetes are at high risk of adverse renal outcomes and death. Albuminuria and angiotensin aldosterone system inhibitor use, which may be a marker of severity of disease, are associated with poor outcomes in early adulthood.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1759123, encodeId=9dbc1e59123ad, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Apr 08 14:07:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900934, encodeId=eee5190093444, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 29 12:07:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636483, encodeId=a7e5163648304, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Nov 08 10:07:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383113, encodeId=57d01383113c1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473628, encodeId=069814e362893, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1759123, encodeId=9dbc1e59123ad, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Apr 08 14:07:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900934, encodeId=eee5190093444, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 29 12:07:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636483, encodeId=a7e5163648304, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Nov 08 10:07:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383113, encodeId=57d01383113c1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473628, encodeId=069814e362893, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
    2012-06-29 hb2008ye
  3. [GetPortalCommentsPageByObjectIdResponse(id=1759123, encodeId=9dbc1e59123ad, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Apr 08 14:07:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900934, encodeId=eee5190093444, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 29 12:07:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636483, encodeId=a7e5163648304, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Nov 08 10:07:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383113, encodeId=57d01383113c1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473628, encodeId=069814e362893, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1759123, encodeId=9dbc1e59123ad, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Apr 08 14:07:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900934, encodeId=eee5190093444, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 29 12:07:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636483, encodeId=a7e5163648304, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Nov 08 10:07:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383113, encodeId=57d01383113c1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473628, encodeId=069814e362893, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1759123, encodeId=9dbc1e59123ad, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Apr 08 14:07:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900934, encodeId=eee5190093444, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 29 12:07:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636483, encodeId=a7e5163648304, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Nov 08 10:07:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383113, encodeId=57d01383113c1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473628, encodeId=069814e362893, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Apr 02 03:07:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]

相关资讯

Diabetes:发现与I型糖尿病相关联的基因表达谱

根据2012年3月8日发表在Diabetes期刊上的一篇文章,对最近被确诊为患上I型糖尿病的病人而言,外周血中的基因表达谱(gene expression profile)与他们第一年的血糖控制情况相关联。 来自澳大利亚布里斯班市亚昆士兰大学迪亚曼蒂纳学院(University of Queensland Diamantina Institute in Brisbane, Australia)的

AJCN:常吃蓝莓和苹果者有助于降低患糖尿病风险

美国研究人员日前发表在《American Journal of Clinical Nutrition》上的一份研究论文显示,常吃蓝莓和苹果者有助于降低患糖尿病风险。不过研究人员也指出,这项研究仅表明这两种水果与糖尿病风险之间的关联,并不意味着吃这两种水果可以预防II型糖尿病。在这项得到美国国家卫生研究院资助的研究中,哈佛大学公共卫生学院的研究者跟踪了约20万名卫生领域专业人士近24年的饮食习惯。研

PNAS:昼夜节律影响肝脏中代谢产物

通过分析肝脏中数百种代谢产物,加州大学欧文分校的表观遗传学与代谢中心研究人员已经发现昼夜节律即我们自己的身体时钟,能极大地控制我们机体的关键构件如氨基酸、碳水化合物和血脂等的产生。 他们确定了600多种肝脏来源的代谢产物,这些产物是由代谢所产生的化学物质,对维持和促进细胞的健康和成长很重要。这些代谢物中约60%被认为是内源性生物钟依赖性的,以往认为只有约15%由生物钟调控。 24小时的昼夜节律

JACC:糖尿病对多血管冠脉血运重建远期转归无显著影响

  韩国学者的一项研究表明,在伴有多血管冠心病的患者中,糖尿病对置入药物洗脱支架(DES)和冠脉旁路移植术(CABG)长期治疗转归无显著影响。论文于2012年3月19日在线发表于《美国心脏病学会杂志》(J Am Coll Cardiol)。   糖尿病是冠心病以及动脉粥样硬化弥漫和进展的重要危险因素。此项研究共纳入伴有多血管冠心病的891例糖尿病患者和2151例非糖尿病患者,并对DES植入和CA

JAHA:肾损伤是糖尿病死亡强大信号

 2012年2月21日,美国心脏学会推出了免费在线杂志——心血管和脑血管疾病杂志(JAHA),报道了一系列卒中、周围动脉疾病、心力衰竭和糖尿病研究的最新研究结果。   一项针对参加临床试验的糖尿病患者心脏和卒中危险因素的研究表明,肾功能损伤是糖尿病患者死亡的最强预测因素。   2型糖尿病使其他心血管危险因素的危险程度增加,例如高血压,高胆固醇血症和肾功能损害。研究人员通过临床试验数据,评估了糖

Diabetes Care:糖尿病患者体质指数与死亡风险关系有种族差异

  美国学者的一项研究表明,在非洲裔美国人和高加索人糖尿病患者中可观察到体质指数(BMI)与死亡风险呈矛盾相关。论文于2012年3月7日在线发表于《糖尿病护理》(Diabetes Care)杂志。   此项前瞻性观察研究共纳入2013例非洲裔美国人、2000例高加索人和143例种族未知的受试者。对BMI、心脏危险因素、用药和代谢当量(MET)最大运动能力进行评估。在各BMI和适应性分类

Baidu
map
Baidu
map
Baidu
map